No need to submit new authorization requests for Neulasta® for HCPCS code J2506

On Jan. 1, 2022, the HCPCS code for Neulasta/Neulasta® Onpro® (pegfilgrastim) changed from J2505 to J2506.

Providers who received an authorization from AIM Specialty Health® for Neulasta under HCPCS code J2505 do not need to submit a new authorization request due to the code change.

Instead, we have updated the Blue Cross / BCN e-referral system so the new HCPCS code J2506 is assigned to the existing Neulasta authorizations.

Check the e-referral system to confirm that your authorizations have been updated to HCPCS code 2506. This change may not be reflected in the AIM provider portal.

In the future, submit prior authorization requests for Neulasta as follows:

We've updated the following drug lists to reflect the code change:

Posted: February 2022
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network